(Additional Details to come from David Hudesman closer to meeting) Breakout Sessions: (Small roundtable groups discussions with faculty. Attendees will pick which faculty their practice most relates to. 30 minutes per sessions with 5-minute break/move to next session. Each attendee will speak with 2 different faculty on topics listed below) -Building a Multidisciplinary Team -Improving Office Workflow Efficiencies -Increasing Patient Volume, Add to this topic: Scheduling pearls -Incorporating Nutrition Support & Psychosocial Services – remote aspects -Incorporating Intestinal Ultrasound in your practice -Maximizing Infusion Services -Partnering with Specialty Pharmacy -Starting a clinical research program (registries and clinical trials) -Education and Mentorship Opportunities

Practical, immediately applicable tips for leveraging AI and EMR tools to streamline your workflow, reduce documentation burden, and reclaim time for your patients.

How to navigate industry relationships across academic and private practice settings. Keys to successful collaborations, avoiding conflicts of interest, and maximizing opportunities.

What to look for and negotiate in an IBD practice contract—academic vs. private practice, RVU structures, protected time, non-competes, and pitfalls and Opportunities

(Very brief mechanism overview (2–3 slides max); High-level efficacy and safety framing; Practical considerations such as route of administration, monitoring, and contraindications; Clear articulation of why and when a therapy is chosen; Majority of time spent on patient-facing explanation and clinical application)

(Very brief mechanism overview (2–3 slides max); High-level efficacy and safety framing; Practical considerations such as route of administration, monitoring, and contraindications; Clear articulation of why and when a therapy is chosen; Majority of time spent on patient-facing explanation and clinical application)

(Very brief mechanism overview (2–3 slides max); High-level efficacy and safety framing; Practical considerations such as route of administration, monitoring, and contraindications; Clear articulation of why and when a therapy is chosen; Majority of time spent on patient-facing explanation and clinical application)

(Very brief mechanism overview (2–3 slides max); High-level efficacy and safety framing; Practical considerations such as route of administration, monitoring, and contraindications; Clear articulation of why and when a therapy is chosen; Majority of time spent on patient-facing explanation and clinical application)

(Very brief mechanism overview (2–3 slides max); High-level efficacy and safety framing; Practical considerations such as route of administration, monitoring, and contraindications; Clear articulation of why and when a therapy is chosen; Majority of time spent on patient-facing explanation and clinical application)

(Include 1 slide case vignette)

(Include 1 slide case vignette)

(Include 1 slide case vignette)

(Include 1 slide case vignette) What’s next when the pouch isn’t working: function vs dysfunction

Lots of practical gastroenterology; show-and-tell cases—what do you do?

Men’s, women’s, and transgender health—non-pregnancy related

Pouchitis, Crohn’s disease, and Crohn’s-like inflammation

Remaining workup for symptoms. video capsule endoscopy, intestinal ultrasound (IUS), cross-sectional imaging, SIBO, bile salt diarrhea, chronic pain

- Pro appendectomy: Paulo Kotze (10min + 2 min rebuttal) - Against appendectomy: Asher Kornbluth (10min + 2 min rebuttal)

- Controlling Perianal Sepsis: Surgical Strategy and Technique – Nicholas McKenna (7min + 3min Q&A) - LIFT for Peri-Anal Fistula: Principles and Surgical Technique – Phillip Fleshner (7min + 3min Q&A) - Rectal Advancement Flap: Principles and Surgical Technique – David Schwartzberg (7min + 3min Q&A)

Remaining workup for symptoms. video capsule endoscopy, intestinal ultrasound (IUS), cross-sectional imaging, SIBO, bile salt diarrhea, chronic pain

Pouchitis, Crohn’s disease, and Crohn’s-like inflammation

Lots of practical gastroenterology; show-and-tell cases—what do you do?

Men’s, women’s, and transgender health—non-pregnancy related

early treatment from diagnosis

advancements in dysplasia

TDM, no more monotherapy

(Initial inpatient evaluation and diagnostic workup, including laboratory assessment, imaging, and the role of endoscopy; early medical decision-making such as steroid initiation; and defining priorities for inpatient management from the gastroenterologist’s standpoint.)

(Indications for surgical consultation, inpatient optimization including steroid management and nutritional support, perioperative decision-making, and key considerations for post-operative care and coordination from the surgical standpoint.)

(Initial inpatient assessment of disease severity, early endoscopic evaluation, laboratory markers including albumin, and urgent medication decisions such as corticosteroids, JAK inhibitors, or anti-TNF therapy to stabilize the patient and set the treatment course.).

(Transitioning safely from IV to oral therapy, optimizing maintenance medication dosing including the role of therapeutic drug monitoring, anticoagulation considerations, discharge planning, and ensuring structured follow-up to reduce relapse and readmission risk.)

defining goals, defining disease, educating patients family friends

prolapse, rashes, change one variable at a time

when not to use adv therapies, change one variable at a time

(Focus on practical applications of non-invasive monitoring tools, including intestinal ultrasound, fecal calprotectin, emerging biomarkers such as sweat calprotectin, and remote or digital monitoring strategies. Emphasize how these tools are used in real-world practice to guide treatment decisions, reduce reliance on endoscopy, and support treat-to-target strategies.)

(Provide a forward-looking overview of emerging therapies and pipeline developments without focusing on detailed clinical trial data. Highlight mechanisms of action at a practical level and explain how these therapies may fit into future clinical decision-making. Reinforce the importance of clinical trial participation and how research advances translate into improved patient care.)

Pulmonary, neurologic, cardiovascular (not joints, skin, liver)

Include microscopic colitis, checkpoint inhibitor colitis, mast cell disease, alpha-gal

Oral, esophageal, gastric, duodenal

- Pro: Alessandro Fichera (10min + 2 min rebuttal) - Against: Phillip Fleshner (10min + 2 min rebuttal) - Q&A (6min)

- The Kono-S anastomosis: Technical Details and Endoscopic Anatomy – Alessandro Fichera (7min + 3min Q&A) - Stapled and Handsewn Ileocolic Anastomoses: Technical Details and Endoscopic Anatomy – Olga Lavryk (7min + 3min Q&A) - Pelvic Pouch Construction: Understanding the Anatomy Seen at Endoscopy - Mantaj Brar (7min + 3min Q&A) (address female fertility considerations – tubes and ovaries)

Christina Ha, MD (Against Dual Therapy) and Ben Cohen, MD (For Dual Therapy)

Pulmonary, neurologic, cardiovascular (not joints, skin, liver)

Oral, esophageal, gastric, duodenal

Include microscopic colitis, checkpoint inhibitor colitis, mast cell disease, alpha-gal

Fistula, fissures, skin tags, ulcers, abscesses, anal ulcers

(Focus on recognizing pseudo–treatment failure and avoiding premature therapy changes. Discuss optimization strategies, including extended induction with upadacitinib when appropriate, and appropriate use and dose optimization of anti-TNF therapies before declaring true failure. Address common misconceptions around early loss of response, inadequate dosing, and timing of assessment, emphasizing when to persist, optimize, or pivot based on clinical and objective data.)

(Examine assumptions that lead to overly restrictive treatment decisions based on age, gender, or comorbidities. Clarify when caution is appropriate versus when it limits optimal care. Emphasize individualized risk assessment, appropriate use of surgery when indicated, and avoiding therapeutic nihilism in complex patients.)